Janney Montgomery Scott LLC increased its stake in Becton Dickinson and Co. (NYSE:BDX) by 22.3% during the second quarter, Holdings Channel reports. The firm owned 39,763 shares of the company’s stock after buying an additional 7,258 shares during the period. Janney Montgomery Scott LLC’s holdings in Becton Dickinson and were worth $6,127,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Bank of Montreal Can bought a new position in shares of Becton Dickinson and during the second quarter valued at about $118,746,000. Emerald Acquisition Ltd. bought a new position in shares of Becton Dickinson and during the second quarter valued at about $102,860,000. UBS Group AG increased its position in shares of Becton Dickinson and by 52.8% in the first quarter. UBS Group AG now owns 1,345,361 shares of the company’s stock valued at $204,253,000 after buying an additional 464,650 shares during the period. JPMorgan Chase & Co. increased its position in shares of Becton Dickinson and by 20.4% in the first quarter. JPMorgan Chase & Co. now owns 2,300,833 shares of the company’s stock valued at $349,312,000 after buying an additional 389,262 shares during the period. Finally, BlackRock Fund Advisors increased its position in shares of Becton Dickinson and by 9.5% in the first quarter. BlackRock Fund Advisors now owns 3,911,925 shares of the company’s stock valued at $593,908,000 after buying an additional 340,497 shares during the period. Institutional investors own 81.96% of the company’s stock.

Becton Dickinson and Co. (NYSE:BDX) traded down 0.77% during midday trading on Friday, hitting $180.15. 732,373 shares of the company were exchanged. The firm has a market capitalization of $38.36 billion, a PE ratio of 34.38 and a beta of 0.97. The stock has a 50 day moving average of $175.12 and a 200 day moving average of $166.62. Becton Dickinson and Co. has a 1-year low of $128.87 and a 1-year high of $181.76.

Becton Dickinson and (NYSE:BDX) last issued its earnings results on Thursday, August 4th. The company reported $2.35 EPS for the quarter, topping analysts’ consensus estimates of $2.21 by $0.14. The company had revenue of $3.20 billion for the quarter, compared to analysts’ expectations of $3.21 billion. Becton Dickinson and had a net margin of 9.24% and a return on equity of 24.26%. The firm’s revenue was up 2.5% compared to the same quarter last year. During the same quarter last year, the company earned $2.05 EPS. On average, equities analysts predict that Becton Dickinson and Co. will post $8.57 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 30th. Investors of record on Friday, September 9th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 1.45%. The ex-dividend date of this dividend is Wednesday, September 7th. Becton Dickinson and’s payout ratio is presently 50.19%.

BDX has been the subject of several research analyst reports. Citigroup Inc. downgraded shares of Becton Dickinson and from a “neutral” rating to a “sell” rating and lowered their price target for the stock from $167.00 to $165.00 in a report on Friday. Bank of America Corp. restated a “buy” rating on shares of Becton Dickinson and in a report on Tuesday, July 12th. Cowen and Company restated an “outperform” rating and issued a $185.00 price objective on shares of Becton Dickinson and in a report on Tuesday, August 16th. Jefferies Group restated a “buy” rating on shares of Becton Dickinson and in a report on Friday, August 5th. Finally, Leerink Swann restated a “hold” rating on shares of Becton Dickinson and in a report on Tuesday, August 9th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. Becton Dickinson and currently has an average rating of “Buy” and a consensus price target of $170.82.

In other Becton Dickinson and news, insider Linda M. Tharby sold 11,704 shares of the business’s stock in a transaction dated Tuesday, September 6th. The shares were sold at an average price of $177.27, for a total value of $2,074,768.08. Following the transaction, the insider now owns 22,146 shares in the company, valued at $3,925,821.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Gary M. Cohen sold 29,367 shares of the business’s stock in a transaction dated Thursday, August 11th. The shares were sold at an average price of $176.81, for a total transaction of $5,192,379.27. Following the completion of the transaction, the insider now owns 125,870 shares in the company, valued at approximately $22,255,074.70. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.

Becton Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

5 Day Chart for NYSE:BDX

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co. (NYSE:BDX).

Receive News & Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related companies with MarketBeat.com's FREE daily email newsletter.